Company news
Vcanbio Cell & Gene Engineering Corp., Ltd. news in 2025
Vcanbio Cell & Gene Engineering Corp., Ltd.'s news releases, calls and decks from 2025, newest first.
with the University of Chinese Academy of Sciences Education Foundation and the Progress in Hosting the Vcanbio Life Sciences Award
December 25, 2025
Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2025
December 15, 2025
Indicative Announcement on Convening the 2nd Extraordinary General Meeting in 2025
December 10, 2025
Announcement on Canceling the Board of Supervisors and Amending the "Articles of Association"
November 27, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025
November 14, 2025
Indicative Announcement on Convening the 1st Extraordinary General Meeting in 2025
November 10, 2025
Announcement on Wholly-owned Subsidiary Obtaining Notice of Approval for Drug Clinical Trials
October 30, 2025
Report for Q3 2025
October 29, 2025
Announcement on the Return of Idle Raised Funds for Cash Management to the Dedicated Fundraising Account
September 25, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction and Semi-annual Report Performance Briefing
September 4, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
August 27, 2025
Announcement on Wholly-owned Subsidiary Obtaining Notice of Acceptance for Application of Drug Clinical Trials
August 4, 2025
Announcement on Resolutions of the 20th Extraordinary Meeting of the 11th Board of Directors
July 29, 2025
Announcement on Resolutions of the 19th Extraordinary Meeting of the 11th Board of Directors
July 9, 2025
Announcement on Extension of Pledge of Partial Equity of Persons Acting in Concert with Controlling Shareholders
June 27, 2025
Announcement on Returning Idle Raised Funds Used for Cash Management to Special Account for Raised Funds
June 24, 2025
Announcement on Wholly-owned Subsidiary Obtaining Notice of Acceptance of Application for Drug Clinical Trial
June 23, 2025
Announcement on Resolution of the 9th Extraordinary Meeting of the 11th Board of Supervisors
May 21, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 20, 2025
Announcement on Convening the 2024 Annual Performance Briefing
May 14, 2025
Announcement on Change of Accounting Policies
April 24, 2025
Announcement on Returning Idle Raised Funds Used for Temporarily Supplementing Current Capital
April 23, 2025
Announcement on the Resignation of Deputy General Manager and Secretary of the Board of Directors
April 9, 2025
Announcement on Returning Idle Raised Funds for Cash Management to Special Account for Raised Funds
March 21, 2025
Announcement on Signing Property Service Entrustment Contract and Related Transactions between Holding Subsidiaries and Tianjin Hongkan Property Operation Management Co., Ltd.
January 8, 2025
Announcement on Obtaining Notice of Acceptance for Drug Clinical Trial Application of the Wholly-owned Subsidiary
January 2, 2025